All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

Variant Bio

Genomic drug discovery company developing therapies by studying people with exceptional health-re...

Seattle, United States11–50Life Sciences
Corporate Round·$171.0M·Jan 2025
AviadoBio

AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerati...

London, United Kingdom51–200Biotech, Genomics
Series B·$168.5M·Apr 2025
10x GenomicsIPO

Biotechnology company providing single-cell genomics analysis tools

Pleasanton, United States1001–5000Biotech, Life Sciences
Series D·$160.5M·Apr 2018
Genome Medical

Telehealth genetic counseling and test-support for patients, providers, and life-sciences partner...

South San Francisco, United States51–200Digital Health, Genomics
Series D·$158.3M·Oct 2024
SA
Scinapsis Analytics

AI-powered biomedical research platform connecting scientists with curated antibody and reagent d...

Toronto, Canada51–200Artificial Intelligence, Biotech
Series D·$155.0M·May 2023
EpizymeIPO

Biopharmaceutical company that is creating innovative drugs for major diseases based on important...

Cambridge, United States201–500Biotech, Drug Discovery
Growth Equity·$154.0M·Nov 2019
Equip Health

Virtual, insurance-covered multidisciplinary treatment delivering family-based eating disorder ca...

San Diego, United States501–1000Life Sciences, Healthcare
Series D·$152.6M·Jul 2025
ElektrofiAcquired

Develops Hypercon hyper-concentrated microparticle formulations to enable subcutaneous delivery o...

Boston, United States51–200Life Sciences, Biotech
Series C·$152.3M·Oct 2024
Avencell

Clinical-stage biopharma developing switchable and allogeneic CAR‑T cell therapies for hard-to-tr...

Watertown, United States51–200Biotech, Genomics
Grant·$152.0M·Jun 2025
Profluent

Born out of pioneering research in artificial intelligence and biology, Profluent Bio develops ma...

Berkeley, United States11–50Life Sciences, Artificial Intelligence
Series B·$150.0M·Nov 2025
Zarminali Pediatrics

Zarminali Pediatrics is a nationwide pediatric multispecialty group providing coordinated primary...

Chicago, United States51–200Life Sciences, Healthcare
Series A·$150.0M·Jan 2026
MasterControl

Quality and regulatory compliance software platform for life sciences companies.

Salt Lake City, United States501–1000Life Sciences, Compliance Software
Growth Equity·$150.0M·Dec 2022
Impel PharmaceuticalsIPO

Creating life-changing, innovative therapies for diseases with an unmet need.

Keller, United States51–200Biotech, Healthcare
Corporate Round·$148.5M·Sep 2021
Science 37Acquired

Operates an FDA-inspected direct-to-patient clinical trial site that enables sponsors to run dece...

Los Angeles, United States201–500Digital Health, Healthcare
Venture Unknown·$148.0M·Aug 2020
Automata

The complete lab automation platform

London, United Kingdom51–200Artificial Intelligence, Life Sciences
Series C·$142.4M·Jan 2026
Cadence

AI-powered remote patient monitoring platform delivering chronic disease management to patients a...

New York201–500Life Sciences
Series B·$141.0M·Dec 2021
Well

AI-driven health engagement platform for employers, using personalized interventions, incentives,...

Chapel Hill, MA201–500Life Sciences, Artificial Intelligence
Series B·$135.0M·Jan 2025
CHARM Therapeutics

AI-driven biotech developing next-generation menin inhibitors and small-molecule therapeutics for...

London, United Kingdom11–50Life Sciences, Biotech
Series B·$130.0M·Sep 2025
Ossium Health

Bioengineering company building the world's first bone marrow bank to enable on-demand stem cell ...

San Francisco, United States51–200Life Sciences, Biotech
Series C·$125.4M·Jul 2023
Inceptive

Foundation models for molecule design, customized for partners to enable novel, broadly accessibl...

Palo Alto, United States11–50Artificial Intelligence, Healthcare
Series A·$120.0M·Sep 2023
Dandy

Dandy is a fully digital dental lab revolutionizing dentistry with AI-powered workflows, real-tim...

New York, United States501–1000Life Sciences
Series C·$120.0M·Sep 2025
Coherus BiosciencesIPO

Develops and commercializes immuno-oncology therapies, including PD-1 inhibitor LOQTORZI, for tre...

Redwood City, United States201–500Biotech, Healthcare
Corporate Round·$119.7M·Jan 2023
Mirvie

Creates precise, actionable, and non-invasive tests for maternal-fetal health Biotech Healthcare

San Francisco Bay Area, United States11–50Life Sciences, Biotech
Venture Unknown·$118.3M·Aug 2025
O
Octant

Therapeutics company pioneering small molecule drug discovery by engineering biology and chemistr...

South San Francisco, United States51–200Biotech, Drug Discovery
Grant·$114.9M·Jun 2025
Nkarta TherapeuticsIPO

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural ...

South San Francisco, United States51–200Biotech, Oncology
Series B·$114.0M·Sep 2019